Cell lines and inhibitors

TG Tarang Gaur
RP Ramulu Poddutoori
LK Leena Khare
BB Bhausaheb Bagal
SR Sonal Rashmi
NP Nikhil Patkar
PT Prashant Tembhare
SP Subramanian PG
DS Dhanlaxmi Shetty
AD Amit Dutt
QZ Qi Zhang
MK Marina Konopleva
UP Uwe Platzbeckar
SG Sudeep Gupta
SS Susanta Samajdar
MR Murali Ramchandra
NK Navin Khattry
SH Syed K. Hasan
ask Ask a question
Favorite

AML cell lines were procured from the European Institute of Oncology (Milan, Italy). Professor Marina Konopleva gifted paired Venetoclax resistant and sensitive MOLM13 cells from MD Anderson, Houston USA [16]. MOLM13 and MV4-11 cells were cultured in the recommended media containing 10% fetal bovine serum (FBS) and 10 mM L-glutamine (Gibco, Thermo Fisher Scientific US) whereas OCI AML2 and OCI AML3 cells were cultured in 20% alpha MEM (Gibco, Thermo Fisher Scientific US) and maintained at 37 °C with 5%CO2. XL102 was developed in collaboration with the Aurigene Oncology Limited, Bangalore. Venetoclax and Cytarabine were purchased from Sellekchem, US.

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A